Loading stock data…
$0.99
Solesence, Inc., a science-driven company, provides engineered materials, formulation development, and commercial manufacturing services in the United States.
Solesence, Inc. in the Consumer Defensive sector is trading at $0.99 with a market capitalization of $61M. The stock is currently near its 52-week low of $0.61, remaining 11.6% below its 200-day moving average. On fundamentals, Piotroski 4/9 shows mixed financial quality, Altman Z in the distress zone. Risk note: RSI 76 is overbought against a weak tape. The Whystock Score of 50/100 suggests a balanced risk-reward profile.
| Metric (USD) | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|
| Total Revenue | $15.33M↑ | $12.96M↑ | $12.48M↓ | $14.60M↓ | $20.36M |
| Gross Profit | $4.75M↑ | $3.34M↓ | $3.43M↑ | $3.37M↓ | $6.44M |
| Operating Income | $121,000↑ | -$504,000↓ | $186,000↑ | -$781,000↓ | $2.48M |
| Net Income | -$158,000↑ | -$766,000↓ | $163,000↑ | -$1.12M↓ | $3.23M |
Solesence, Inc., a science-driven company, provides engineered materials, formulation development, and commercial manufacturing services in the United States. The company engages in the manufacture and supply of surface engineered zinc oxide and tita...